Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
32 hedge funds and large institutions have $157M invested in Aratana Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
950% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 2
316% more capital invested
Capital invested by funds: $37.8M → $157M (+$119M)
146% more funds holding
Funds holding: 13 → 32 (+19)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$43.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.99M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.94M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$787K |
| 5 |
Goldman Sachs
New York
|
+$713K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.28M |
| 2 |
JP Morgan Chase
New York
|
-$2.87M |
| 3 |
HHC
Hutchin Hill Capital
New York
|
-$631K |
| 4 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$190K |
| 5 |
RSCM
Rail-Splitter Capital Management
Chicago,
Illinois
|
-$189K |
PETX Hedge Fund Activity: Q3 2013 in Review
32 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2013, worth a combined $157M — up 316% from $37.8M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PETX positions and 2 closed out — a net gain of 19 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was MPM Asset Management, adding an estimated $43.8M. The largest seller was Wellington Management Group, cutting an estimated $6.28M.
- 32 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2013, up from 13 in Q2 2013.
- Funds reported $157M of Aratana Therapeutics, Inc. stock for Q3 2013, up 316% quarter-over-quarter.
- 21 funds opened new Aratana Therapeutics, Inc. positions in Q3 2013 and 2 closed out, a net change of +19 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q3 2013 was MPM Asset Management, an estimated $43.8M added.
- The largest Aratana Therapeutics, Inc. seller in Q3 2013 was Wellington Management Group, an estimated $6.28M sold.
Based on aggregated 13F filings for Q3 2013.